MedPath

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Phase 2
Terminated
Conditions
Crohn's Disease
Registration Number
NCT00562887
Lead Sponsor
Abbott
Brief Summary

To compare the efficacy, safety and pharmacokinetics of ABT-874 to placebo in subjects who have moderately to severely active Crohn's Disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
246
Inclusion Criteria
  • Diagnosis of Crohn's disease for greater than 4 months confirmed by endoscopy or radiologic evaluation.
  • CDAI score of >= 220 and <= 450 at Week 0.
  • Males and females >= 18 years and < 75 years of age at the Screening visit.
  • Judged to be in generally good health as determined by the Investigator.
Exclusion Criteria
  • Current diagnosis of the colitis other than Crohn's disease.
  • Symptomatic known strictures.
  • Surgical bowel resections within the past 6 months or is planning any resection at any time point while enrolled in the study.
  • Ostomy or ileoanal pouch. (Subjects with a previous ileo-rectal anastomosis are not excluded).
  • Short bowel syndrome as determined by the investigator.
  • Infection or risk factors for severe infections.
  • Females who are pregnant or considering becoming pregnant during the study, or breast-feeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of subjects achieving clinical remission, defined as CDAI score of <150 pointsWeek 6
Secondary Outcome Measures
NameTimeMethod
Patient reported outcomes, clinical response indicators, safety parametersWeeks 12 and 24

Trial Locations

Locations (61)

Site Ref # / Investigator 6792

🇺🇸

Orange, California, United States

Site Ref # / Investigator 6643

🇺🇸

San Diego, California, United States

Site Ref # / Investigator 6670

🇺🇸

Hamden, Connecticut, United States

Site Ref # / Investigator 6694

🇺🇸

Gainesville, Florida, United States

Site Ref # / Investigator 6794

🇺🇸

Jacksonville, Florida, United States

Site Ref # / Investigator 6687

🇺🇸

Winter Park, Florida, United States

Site Ref # / Investigator 6667

🇺🇸

Zephyrhills, Florida, United States

Site Ref # / Investigator 6691

🇺🇸

Atlanta, Georgia, United States

Site Ref # / Investigator 6642

🇺🇸

Atlanta, Georgia, United States

Site Ref # / Investigator 8797

🇺🇸

Macon, Georgia, United States

Scroll for more (51 remaining)
Site Ref # / Investigator 6792
🇺🇸Orange, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.